Meta-analysis of monotherapy versus combination therapy for pulmonary arterial hypertension

American Journal of Cardiology

Volumn 108, Issue 8, 2011, Pages 1177-1182

  Fox, Benjamin D ^a,b   Shimony, Avi ^a,c   Langleben, David ^a  

^a MCGILL UNIVERSITY   (Canada)

^b TEL AVIV UNIVERSITY   (Israel)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BOSENTAN; ILOPROST; PROSTACYCLIN; SILDENAFIL; TADALAFIL; UNIPROST;

ARTICLE; DISEASE EXACERBATION; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; LUNG TRANSPLANTATION; META ANALYSIS; MONOTHERAPY; MORTALITY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SYSTEMATIC REVIEW; WALKING;

ANTIHYPERTENSIVE AGENTS; HUMANS; HYPERTENSION, PULMONARY; LUNG TRANSPLANTATION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84860404865     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2011.06.021     Document Type: Article

References (23)

1. V.V. McLaughlin, S.L. Archer, D.B. Badesch, R.J. Barst, H.W. Farber, J.R. Lindner, M.A. Mathier, M.D. McGoon, M.H. Park, R.S. Rosenson, L.J. Rubin, V.F. Tapson, J. Varga, R.A. Harrington, J.L. Anderson, E.R. Bates, C.R. Bridges, M.J. Eisenberg, V.A. Ferrari, C.L. Grines, M.A. Hlatky, A.K. Jacobs, S. Kaul, R.C. Lichtenberg, J.R. Lindner, D.J. Moliterno, D. Mukherjee, G.M. Pohost, R.S. Rosenson, R.S. Schofield, S.J. Shubrooks, J.H. Stein, C.M. Tracy, H.H. Weitz, and D.J. Wesley ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association Circulation 119 2009 2250 2294
2. R.J. Barst, L.J. Rubin, W.A. Long, M.D. McGoon, S. Rich, D.B. Badesch, B.M. Groves, V.F. Tapson, R.C. Bourge, B.H. Brundage, S.K. Koerner, D. Langleben, C.A. Keller, S. Murali, B.F. Uretsky, L.M. Clayton, M.M. Jobsis, S.D. Blackburn, D. Shortino, J.W. Crow The Primary Pulmonary Hypertension Study Group A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension N Engl J Med 334 1996 296 302
3. L.J. Rubin, D.B. Badesch, R.J. Barst, N. Galie, C.M. Black, A. Keogh, T. Pulido, A. Frost, S. Roux, I. Leconte, M. Landzberg, and G. Simonneau Bosentan therapy for pulmonary arterial hypertension N Engl J Med 346 2002 896 903 (Pubitemid 34984638)
4. N. Gali, H.A. Ghofrani, A. Torbicki, R.J. Barst, L.J. Rubin, D. Badesch, T. Fleming, T. Parpia, G. Burgess, A. Branzi, F. Grimminger, M. Kurzyna, G. Simonneau Sildenafil Use in Pulmonary Arterial Hypertension (SUPER) Study Group Sildenafil citrate therapy for pulmonary arterial hypertension N Engl J Med 353 2005 2148 2157 (Pubitemid 41653106)
5. A. Macchia, R. Marchioli, G. Tognoni, M. Scarano, R. Marfisi, L. Tavazzi, and S. Rich Systematic review of trials using vasodilators in pulmonary arterial hypertension: why a new approach is needed Am Heart J 159 2010 245 257
6. M.L. Toews, and D.B. Bylund Pharmacologic principles for combination therapy Proc Am Thorac Soc 2 2005 282 289 (Pubitemid 41566936)
7. G. Simonneau, L.J. Rubin, N. Gali, R.J. Barst, T.R. Fleming, A.E. Frost, P.J. Engel, M.R. Kramer, G. Burgess, L. Collings, N. Cossons, O. Sitbon, D.B. Badesch PACES Study Group Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial Ann Intern Med 149 2008 521 530
8. V.V. McLaughlin, R.L. Benza, L.J. Rubin, R.N. Channick, R. Voswinckel, V.F. Tapson, I.M. Robbins, H. Olschewski, M. Rubenfire, and W. Seeger Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial J Am Coll Cardiol 55 2010 1915 1922
9. T. Abraham, G. Wu, F. Vastey, J. Rapp, N. Saad, and E. Balmir Role of combination therapy in the treatment of pulmonary arterial hypertension Pharmacotherapy 30 2010 390 404
10. A.R. Jadad, R.A. Moore, D. Carroll, C. Jenkinson, D.J. Reynolds, D.J. Gavaghan, and H.J. McQuay Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17 1996 1 12 (Pubitemid 26120810)
11. R. DerSimonian, and N. Laird Meta-analysis in clinical trials Control Clin Trials 7 1986 177 188 (Pubitemid 17189972)
12. R Development Core Team R: A Language and Environment for Statistical Computing 2010 R Foundation for Statistical Computing Vienna, Austria
13. Schwarzer G. Meta-Analysis with R. R Package Version 1.6-1. 2010.
14. D. Moher, A. Liberati, J. Tetzlaff, and D.G. Altman Preferred Reporting Items for Systematic Reviews and Meta-analyses: the PRISMA Statement PLoS Med 6 2009 e1000097
15. N. Gali, B.H. Brundage, H.A. Ghofrani, R.J. Oudiz, G. Simonneau, Z. Safdar, S. Shapiro, R.J. White, M. Chan, A. Beardsworth, L. Frumkin, R.J. Barst Pulmonary Arterial Hypertension and Response to Tadalafil (PHIRST) Study Group Tadalafil therapy for pulmonary arterial hypertension Circulation 119 2009 2894 2903
16. R.J. Barst, R.J. Oudiz, A. Beardsworth, B.H. Brundage, G. Simonneau, H.A. Ghofrani, D.P. Sundin, N. Gali Pulmonary Arterial Hypertension and Response to Tadalafil (PHIRST) Study Group Tadalafil monotherapy and as add-on to background bosentan in patients with pulmonary arterial hypertension J Heart Lung Transplant 30 2011 632 643
17. V.V. McLaughlin, R.J. Oudiz, A. Frost, V.F. Tapson, S. Murali, R.N. Channick, D.B. Badesch, R.J. Barst, H.H. Hsu, and L.J. Rubin Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertension Am J Respir Crit Care Med 174 2006 1257 1263 (Pubitemid 44924827)
18. M.M. Hoeper, H. Leuchte, M. Halank, H. Wilkens, F.J. Meyer, H.J. Seyfarth, R. Wensel, F. Ripken, H. Bremer, S. Kluge, G. Hoeffken, and J. Behr Combining inhaled iloprost with bosentan in patients with idiopathic pulmonary arterial hypertension Eur Respir J 28 2006 691 694 (Pubitemid 46331988)
19. M. Humbert, R.J. Barst, I.M. Robbins, R.N. Channick, N. Gali, A. Boonstra, L.J. Rubin, E.M. Horn, A. Manes, and G. Simonneau Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2 Eur Respir J 24 2004 353 359 (Pubitemid 39232254)
20. N. Gali, L. Negro, and G. Simonneau The use of combination therapy in pulmonary arterial hypertension: new developments Eur Respir Rev 18 2009 148 153
21. M.M. Hoeper, I. Markevych, E. Spiekerkoetter, T. Welte, and J. Niedermeyer Goal-oriented treatment and combination therapy for pulmonary arterial hypertension Eur Respir J 26 2005 858 863 (Pubitemid 41632043)
22. H.A. Ghofrani, N.W. Morrell, M.M. Hoeper, H. Olschewski, A.J. Peacock, R.J. Barst, S. Shapiro, H. Golpon, M. Toshner, F. Grimminger, and S. Pascoe Imatinib in pulmonary arterial hypertension patients with inadequate response to established therapy Am J Respir Crit Care Med 182 2010 1171 1177
23. M.R. Wilkins, O. Ali, W. Bradlow, J. Wharton, A. Taegtmeyer, C.J. Rhodes, H.A. Ghofrani, L. Howard, P. Nihoyannopoulos, R.H. Mohiaddin, J.S. Gibbs Simvastatin Pulmonary Hypertension Trial (SiPHT) Study Group Simvastatin as a treatment for pulmonary hypertension trial Am J Respir Crit Care Med 181 2010 1106 1113